News Pfizer, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 12:28:33 2024-05-06 pm EDT			5-day change	1st Jan Change
28.16 ^USD	+1.24%		+9.75%	-2.26%

02:14pm	Pfizer: Citi analyst appointed Chief Strategy Officer	CF
01:45pm	Pfizer Names Andrew Baum as Chief Strategy, Innovation Officer	MT

Pfizer: Citi analyst appointed Chief Strategy Officer	08:14am	CF
Pfizer Names Andrew Baum as Chief Strategy, Innovation Officer	07:45am	MT
Pfizer Names Andrew Baum Chief Strategy, Innovation Officer	07:22am	DJ
BioNTech says 90% of 2024 revenues will accrue at end of year	07:03am	RE
Pfizer Announces New Chief Strategy and Innovation Officer	06:46am	BU
Moderna Litigation Against BioNTech And Pfizer Stayed Pending IPR	06:11am	AQ
Northeast Pharmaceutical's Unit Gets Nod to Produce Azithromycin for Injection	02:50am	MT
GSK Sues Pfizer, Pharmacia & Upjohn & BioNTech For Infringing MRNA Vaccine Patents	May. 03	AQ
NICE recommends new haemolytic anaemia treatment	May. 03	AQ
AM Best Affirms Credit Ratings of Blue Whale Re Ltd	May. 03	AQ
GSK plc : Back on track	May. 03
Wall Street: optimism ahead of NFP, rates ease	May. 02	CF
PFIZER INC : Buy rating from DZ Bank	May. 02	ZD
Morgan Stanley Adjusts Price Target on Pfizer to $29 From $28	May. 02	MT
Leerink Adjusts Price Target on Pfizer to $29 From $27	May. 02	MT
BMO Capital Adjusts Pfizer's Price Target to $36 From $33, Keeps Outperform Rating	May. 02	MT
Pfizer : Quarterly Corporate Performance - First Quarter 2024 Prepared Remarks	May. 02	PU
Pfizer : Quarterly Corporate Performance - First Quarter 2024 Infographic	May. 02	PU
Moderna quarterly sales beat expectations but plummet from previous year	May. 02	RE
Morgan Stanley Lifts Price Target on Pfizer to $29 From $28, Keeps Equalweight Rating	May. 02	MT

No results for this search

Pfizer, Inc: A cycle for nothing?

December 14, 2023 at 10:58 am EST

Albert Bourla, Pfizer CEO (full interview): mRNA, acquisitions, weight-loss drugs